Eric dEsparbes

Insider Reports History

Entity
Individual
Location
Theravance, Inc., 951 Gateway Blvd., South San Francisco, CA
Signature
/s/ Clarke Neumann, Attorney-in-Fact for Eric d'Esparbes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric dEsparbes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIORA THERAPEUTICS, INC. Chief Financial Officer Common Stock 576K $386K $0.67 Aug 15, 2024 Direct

Insider Reports Filed by Eric dEsparbes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BIOR BIORA THERAPEUTICS, INC. Aug 15, 2024 1 -$18.6K 4 Aug 16, 2024 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Feb 15, 2024 1 $0 4 Feb 15, 2024 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Aug 15, 2023 2 -$126K 4 Aug 17, 2023 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. May 15, 2023 1 -$9.4K 4 May 17, 2023 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Mar 15, 2023 3 -$28.7K 4 Mar 17, 2023 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Feb 15, 2023 1 -$931 4 Feb 17, 2023 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Nov 15, 2022 1 -$1.4K 4 Nov 16, 2022 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Aug 15, 2022 1 -$6.19K 4 Aug 16, 2022 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. May 15, 2022 3 -$7.79K 4 May 17, 2022 Chief Financial Officer
BIOR PROGENITY, INC. Apr 15, 2022 2 $0 4 Apr 19, 2022 Chief Financial Officer
BIOR PROGENITY, INC. Feb 15, 2022 1 -$9.35K 4 Feb 17, 2022 Chief Financial Officer
BIOR PROGENITY, INC. Aug 15, 2021 1 -$9.49K 4 Aug 17, 2021 Chief Financial Officer